If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarshalls Regulatory News (MSLH)

Share Price Information for Marshalls (MSLH)

Share Price is delayed by 15 minutes
Get Live Data
151.60    0.60 (0.40%)
Bid:
151.80
Ask:
152.10
Spread: 0.30 (0.198%)
Market Cap: £383.38m
MSLH Live PriceLast checked at - London Stock Exchange

Intraday Marshalls Share Chart

COVID-19 update

27 Mar 2020 07:00

RNS Number : 7918H
Marshalls PLC
27 March 2020
Β 

27 March 2020

LEI: 213800S21IFC367J5V62

Β 

Β 

COVID-19 update

Β 

Marshalls plc, the specialist landscape products group, issues an update on the impact and the measures it is taking in response to the COVID-19 outbreak.

Β 

In view of the Government's increasing measures to contain the spread of the virus in the current challenging environment, the Group is taking actions to ensure the health and wellbeing of employees, customers and suppliers and to support the long-term interest of the business.

Β 

Operational actions

Β 

The Group is implementing an agile, operational plan to manage all parts of the business safely, whilst continuing to support customers where there is demand. We are continuing to distribute product where demand exists, but in those parts of the business where demand has fallen we are managing the manufacturing facilities carefully and commencing a process of temporary suspension of operations. These actions will protect cash flow generation and contain costs. Non-essential capital expenditure has been deferred, but not at the expense of health and safety. Our operational planning is dynamic and able to react to the changing environment. The majority of our office-based employees are now safely working from home. We are adhering closely to official UK Government guidance.

Β 

Financial position

Β 

The Group has a strong balance sheet supported by a flexible capital structure and we maintain significant headroom against bank facilities. We conduct deep stress testing on a regular basis to support this position. We have a range of committed facilities in place with a spread of maturity dates that extend out to 2024. The Group's total bank facilities are currently Β£165 million of which Β£140 million are committed. As at 25 March the Group had Β£93 million of net debt (on a pre-IFRS 16 basis) of which Β£82 million was committed. Consequently, Β£72 million of facilities remain unutilised of which Β£58 million is committed.

Β 

Our bank covenants are for the ratio of EBITA to interest charge to be greater than 2.5 times and for the ratio of net debt to EBITDA to be less than 3.0 times. All bank covenants are on a pre-IFRS 16 basis. Interest cover and net debt to EBITDA covenants were comfortably met for the year ended 31 December 2019 at 42.6 times and 0.2 times respectively.

Β 

We maintain positive and constructive relationships with all our banking partners. Our short term cash flows will also benefit from many of the initiatives announced by the Government.

Β 

2019 Final and Supplementary dividends

Β 

In the current circumstances, however, the Board believes it is important to preserve the Group's strong financial position and, consequently, that it is now appropriate to cancel the 2019 final dividend of 9.65 pence and the previously announced supplementary dividend of 4.00 pence. These were previously proposed with the announcement of the full year results for 2019 on 12 March 2020. As a result, the approval of these previously proposed dividends will not be put before shareholders at the AGM. The cash saving from this measure will be Β£27.1 million.

Β 

Outlook

Β 

As a consequence of the current levels of uncertainty, which are unprecedented, it is not possible at this time for the Group to provide an accurate assessment of trading for the current year and accordingly all previous market guidance is now being withdrawn. We will provide a further update when there is greater clarity about the impact of COVID-19.

Β 

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) ("MAR") prior to its release as part of this announcement and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

Β 

Β 

Enquiries:

Martyn Coffey

Chief Executive

Marshalls plc

+44 (0)1422 314777

Jack Clarke

Group Finance Director

Β 

Marshalls plc

+44 (0)1422 314777

Andrew Jaques

MHP Communications

+44 (0)20 3128 8540

Charlie Barker

Β 

Β 

Note to the Editor:

Β 

About Marshalls:

Β 

Established in the late 1880s, Marshalls is the UK's leading manufacturer of superior natural stone and innovative concrete hard landscaping products, supplying the construction, home improvement and landscape markets. Marshalls provides the product ranges, design services, technical expertise, innovative ideas and inspiration to transform gardens, drives and public and commercial landscapes.

Β 

Marshalls operates its own quarries and manufacturing sites throughout the UK, including a national network of manufacturing and distribution sites, and has operations in Belgium and sales representation in other international markets. As a major plc, Marshalls is committed to quality in everything it does, including the achievement of high environmental and ethical standards and continual improvement in health and safety performance.

Β 

Forward-Looking Statements:

Β 

Any statements in this release, to the extent that they are forward-looking, are subject to risk factors associated with, amongst other things, the economic and business circumstances occurring from time to time in the markets in which Marshalls operates. It is believed that the expectations reflected in these statements are reasonable but they may be affected by a wide range of variables which could cause actual results to differ materially from those currently anticipated. More information about the factors that may affect Marshalls' performance is contained in the Annual Report to shareholders for the year ended 31 December 2018.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
UPDEANDKADNEEFA
Date   Source Headline
15th Dec 201512:02 pmRNSDirector/PDMR Shareholding
10th Dec 20157:00 amRNSTrading Update
4th Dec 20158:47 amRNSDirector/PDMR Shareholding
4th Nov 20159:38 amRNSDirector/PDMR Shareholding
23rd Oct 20157:00 amRNSAnalyst and Investor Visit
16th Oct 20153:01 pmRNSHolding(s) in Company
12th Oct 201511:51 amRNSHolding(s) in Company
9th Oct 201511:14 amRNSHolding(s) in Company
5th Oct 20154:33 pmRNSDirector/PDMR Shareholding
23rd Sep 20154:10 pmRNSHolding(s) in Company
4th Sep 201511:53 amRNSDirector/PDMR Shareholding
3rd Sep 20154:38 pmRNSDirector/PDMR Shareholding
3rd Sep 201510:10 amRNSHolding(s) in Company
2nd Sep 20151:43 pmRNSHolding(s) in Company
1st Sep 20154:30 pmRNSDirector/PDMR Shareholding
28th Aug 20157:00 amRNSHalf Yearly Report
3rd Aug 20154:15 pmRNSDirector/PDMR Shareholding
6th Jul 20157:00 amRNSTrading Update
3rd Jul 20153:55 pmRNSDirector/PDMR Shareholding
9th Jun 20152:35 pmRNSHolding(s) in Company
3rd Jun 20154:02 pmRNSDirector/PDMR Shareholding
20th May 20153:45 pmRNSAGM Statement
20th May 20157:00 amRNSTrading Update
11th May 20154:09 pmRNSHolding(s) in Company
6th May 20153:57 pmRNSDirector/PDMR Shareholding
9th Apr 20154:17 pmRNSAnnual Financial Report
8th Apr 20153:58 pmRNSHolding(s) in Company
2nd Apr 20155:33 pmRNSDirector/PDMR Shareholding
10th Mar 20154:49 pmRNSDirector/PDMR Shareholding
9th Mar 20153:51 pmRNSDirector Declaration
6th Mar 20157:00 amRNSDirectorate Change
6th Mar 20157:00 amRNSFinal Results
4th Mar 20158:58 amRNSDirector/PDMR Shareholding
4th Feb 20159:13 amRNSDirector/PDMR Shareholding
19th Jan 201510:36 amRNSAppointment of Joint Broker
7th Jan 20157:00 amRNSTrading Update
5th Jan 20154:17 pmRNSDirector/PDMR Shareholding
15th Dec 201411:45 amRNSHolding(s) in Company
3rd Dec 20144:13 pmRNSDirector/PDMR Shareholding
7th Nov 20147:00 amRNSPresentation to Investors and Analysts
5th Nov 20147:00 amRNSInterim Management Statement
4th Nov 201411:06 amRNSDirector/PDMR Shareholding
13th Oct 20145:04 pmRNSHolding(s) in Company
6th Oct 201411:13 amRNSDirector/PDMR Shareholding
2nd Oct 20142:23 pmRNSDirector/PDMR Shareholding
1st Oct 20141:46 pmRNSRetirement of Directors - Remuneration Statement
1st Oct 20141:24 pmRNSDirectorate Change
16th Sep 20143:38 pmRNSHolding(s) in Company
3rd Sep 20144:09 pmRNSDirector/PDMR Shareholding
1st Sep 20142:58 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.